Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects
The cannabinoid system has been identified as a critical endogenous regulator of immune homeostasis through immunomodulatory actions. This system is one of the main regulatory systems of the central nervous system (CNS). Variations in the cannabinoid CB2 receptor gene (CNR2) could affect intracellular signaling and reduce system function, which has been associated with an unbalanced immune response and increased risk of a variety of autoimmune inflammatory disorders. The present study investigated the relationship between CNR2 rs35761398 (Q63R) functional variation and multiple sclerosis (MS). A total of 100 Iranian MS patients and 100 healthy controls were enrolled in the study and genotyped through TaqMan assay. The co-dominant, dominant, recessive, over-dominant, and additive inheritance models were analyzed using SNPStats software. A significant genetic association was observed between Q63R polymorphism and MS. The dominant model was accepted as the best inheritance model to fit the data (OR 2.70, 95% CI 1.47–4.97, p = 0.001). The data implied the involvement of the CNR2 gene in susceptibility to MS in Iranian patients.
KeywordsCannabinoid receptor type 2 Multiple sclerosis Single-nucleotide polymorphism CNR2 Q63R Iran
cannabinoid receptor type 2
juvenile idiopathic arthritis
inflammatory bowel disease
Akaike information criterion
central nerve system
The authors would like to thank all the participants in the current study.
This work was financially supported by Golestan University of Medical Sciences (No. 231195).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
The current human study was approved by the science and bioethics committee of Golestan University of Medical Sciences (IR.GOUMS.REC.1397.045).
- Coppola N, Zampino R, Bellini G, Macera M, Marrone A, Pisaturo M, Boemio A, Nobili B, Pasquale G, Maione S, Adinolfi LE, Perrone L, Sagnelli E, Miraglia Del Giudice E, Rossi F (2014) Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chroni hepatitis C. Clin Gastroenterol Hepatol 12:334–340CrossRefGoogle Scholar
- Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Adinolfi LE2, Giudice EM, Gentile I, Sagnelli E, Rossi F (2016) CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. Dig Liver Dis 48:1364–1369Google Scholar
- Ehsan M, Xixis KL (2018) Sclerosis, multiple. StatPearls [internet]. StatPearls publishingGoogle Scholar
- Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ (2004) Genetic markers: progress and potential for cardiovascular disease. Circulation 109: IV-47-IV-58Google Scholar
- Ismail M, Khawaja G (2018) Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis 37: 2933-2938Google Scholar
- McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRefGoogle Scholar
- Rivas Alonso V, Flores Rivera JJ, Rito García Y, Corona T (2017) The genetics of multiple sclerosis in Latin America. Mult Scler J Exp Transl Clin 3:2055217317727295Google Scholar
- Rossi F, Bellini G, Tolone C, Luongo L, Mancusi S, Papparella A, Sturgeon C, Fasano A, Nobili B, Perrone L, Maione S, del Giudice EM (2012a) The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. Pharmacol Re 66:88–94CrossRefGoogle Scholar
- Tahamtan A, Samieipoor Y, Nayeri FS, Rahbarimanesh AA, Izadi A, Rashidi-Nezhad A, Tavakoli-Yaraki M, Farahmand M, Bont L, Shokri F, Mokhatri-Azad T, Salimi V (2018) Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Virulence 9:217–230CrossRefGoogle Scholar
- Yonal O, Eren F, Yılmaz Y, Atuğ Ö, Över HH (2014) No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. Turk J Gastroenterol 25:639–643Google Scholar